Drug Database
Back to search

Sweden· SE-20120503000025

Fyremadel 0,25 mg/0,5 ml Injektionsvätska, lösning i förfylld spruta

A medicinal product containing ganirelix, registered in Sweden by Sun Pharmaceutical Industries Europe B.V..

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedFyremadel 0,25 mg/0,5 ml Injektionsvä…ATC—REGISTER NO.SE-20120503000025PACKS LISTED1CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ganirelixAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Ganirelix
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20120503000025

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ganirelix in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganirelix products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Ganirelix Astro, Ganirelix Theramex
  • Belgium · Fyremadel, Ovamex
  • Bulgaria · Ganirelix Theramex
  • Czechia · Fyremadel
  • Germany · Fyremadel, Ganiran
  • Denmark · Fyremadel, Ganirelix Orifarm
  • Estonia · Ganirelix Theramex
  • Spain · Astarté, Fyremadel
  • Finland · Fyremadel, Ganirelix Orifarm
  • France · Fyremadel, Ganirelix Eg
  • United Kingdom (Northern Ireland) · Fyremadel
  • Greece · Fyremadel, Ovamex
  • Croatia · Ganireliks Theramex
  • Hungary · Ganirelix Theramex
  • Iceland · Ganirelix, Ganirelix Gedeon Richter
  • Italy · Fyremadel, Ovamex
  • Liechtenstein · Ganirelix, Ganirelix Gedeon Richter
  • Lithuania · Ganirelix Theramex
  • Latvia · Ganirelix Theramex
  • Netherlands · Fyremadel, Ganirelix Fagron
  • Norway · Fyremadel, Ganirelix
  • Poland · Fyremadel, Ovamex
  • Portugal · Astarté, Fyremadel
  • Slovenia · Ganireliks Theramex
  • Slovakia · Fyremadel, Ganirelix Theramex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/64edb75d-0814-469a-8750-97a8e793b297
GET /v1/drugs/64edb75d-0814-469a-8750-97a8e793b297?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20120503000025",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120503000025",
  "product_doc_link": "https://docetp.mpa.se/LMF/Fyremadel%20solution%20for%20injection%2C%20prefilled%20syringe%20SmPC_09001bee807a46c9.pdf"
}
API referenceMCP serverPlans

See everything about ganirelix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console